Our co-clinical drug testing platform allows you to test your clinical candidate in patient-derived organoids from patients enrolled in clinical trials. These organoids serve as miniaturized replicas of the patient’s biology, enabling you to gain invaluable patient insights like never before.
Bring patients enrolled in clinical trials into the lab by developing new organoid models
Gauge the efficacy of your drug by simulating clinical trials in organoids
Prioritise participant enrollment by identifying responders and non-responders in prospective trials
Delve into the underlying mechanism of response or non-response and discover novel biomarkers
PUBLICATION
